Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

6.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Mismatch Repair01:20

Mismatch Repair

6.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.8K
Mismatch Repair01:36

Mismatch Repair

44.3K
Overview
44.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Origins of nonsense mutations in human tumor suppressor genes.

Mutation research·2021
Same author

Origin of mutations in genes associated with human glioblastoma multiform cancer: random polymerase errors versus deamination.

Heliyon·2019
Same author

The power of agricultural data.

Science (New York, N.Y.)·2018
Same author

Thermodynamic Stability of DNA Duplexes Comprising the Simplest T → dU Substitutions.

Biochemistry·2018
Same author

The Adenomatous Polyposis Coli (APC) mutation spectra in different anatomical regions of the large intestine in colorectal cancer.

Mutation research·2018
Same author

Origin of Somatic Mutations in β-Catenin versus Adenomatous Polyposis Coli in Colon Cancer: Random Mutagenesis in Animal Models versus Nonrandom Mutagenesis in Humans.

Chemical research in toxicology·2017
Same journal

Evaluation and interpretation of chemical genotoxicity risks; Strategies for method development.

Mutation research. Genetic toxicology and environmental mutagenesis·2026
Same journal

Oxide-nanoparticles induce in vitro DNA damage and genomic instability in human peripheral blood cells.

Mutation research. Genetic toxicology and environmental mutagenesis·2026
Same journal

LA-COMET group: In vivo application of the comet assay in animal and plant models, including wild species.

Mutation research. Genetic toxicology and environmental mutagenesis·2026
Same journal

Evaluation of applicability of the repeated-dose liver micronucleus assay in rats initiated at８weeks of age as in vivo genotoxicity assessment for 2,6-dninitrotoluene (2,6-DNT), a compound with reported cytostatic potential.

Mutation research. Genetic toxicology and environmental mutagenesis·2026
Same journal

Biomarkers and bioindicators of genotoxicity assessment of solid waste emissions from India: Insights into mechanisms of its genome instability.

Mutation research. Genetic toxicology and environmental mutagenesis·2026
Same journal

Alkaline comet assay in human biomonitoring studies by the Latin America / LA-COMET group.

Mutation research. Genetic toxicology and environmental mutagenesis·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

20.0K

Somatic mutations in cancer: Stochastic versus predictable.

Barry Gold1

  • 1Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, 15261, USA.

Mutation Research. Genetic Toxicology and Environmental Mutagenesis
|February 1, 2017
PubMed
Summary
This summary is machine-generated.

Cancer driver gene mutations are not random. Specific DNA changes at CGA codons in tumor suppressor genes, linked to 5-methylcytosine deamination, explain mutation patterns in cancers like colorectal cancer (CRC) and ovarian cancer (OVC).

Keywords:
CancerDNA methylationDeaminationSomatic mutations

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.0K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.2K

Related Experiment Videos

Last Updated: Mar 8, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

20.0K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.0K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.2K

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The origins of most human cancers are unclear, with known causes including environmental mutagens and germline mutations.
  • Cancer etiology is partly attributed to stochastic factors like stem cell divisions and random DNA polymerase errors.
  • Somatic mutations in cancer driver genes, however, exhibit non-random patterns.

Purpose of the Study:

  • To investigate the non-stochastic nature of mutations in cancer driver genes.
  • To identify specific mutation patterns and their underlying mechanisms in tumor suppressor genes.
  • To propose expanded risk factors for cancer prediction.

Main Methods:

  • Analysis of nonsense mutations in the APC and TP53 tumor suppressor genes in colorectal cancer (CRC) and ovarian cancer (OVC).
  • Examination of mutation patterns at CGA codons, particularly those leading to stop codons.
  • Correlation of mutation patterns with the hydrolytic deamination of 5-methylcytosine at methylated CpG sites.

Main Results:

  • Nonsense mutations in the APC gene in CRC are not random, with a disproportionate number occurring at CGA codons.
  • CGA codons are significantly overrepresented in TP53 mutations in CRC and OVC.
  • The observed mutation patterns are consistent with deamination of 5-methylcytosine at CpG sites, leading to C→T transitions and stop codons.

Conclusions:

  • Mutations in cancer driver genes are not purely stochastic and can be influenced by specific molecular mechanisms.
  • The methylation status of gene body CGA codons in tumor suppressor genes is a critical factor in cancer development.
  • Predictive risk factors for cancer should include DNA methylation patterns alongside random polymerase errors.